A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio.
about
A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
A Fas Ligand (FasL)-Fused Huma ...... lls with a Low FasL/Fas Ratio.
@ast
A Fas Ligand (FasL)-Fused Huma ...... lls with a Low FasL/Fas Ratio.
@en
type
label
A Fas Ligand (FasL)-Fused Huma ...... lls with a Low FasL/Fas Ratio.
@ast
A Fas Ligand (FasL)-Fused Huma ...... lls with a Low FasL/Fas Ratio.
@en
prefLabel
A Fas Ligand (FasL)-Fused Huma ...... lls with a Low FasL/Fas Ratio.
@ast
A Fas Ligand (FasL)-Fused Huma ...... lls with a Low FasL/Fas Ratio.
@en
P2093
P2860
P1476
A Fas Ligand (FasL)-Fused Huma ...... lls with a Low FasL/Fas Ratio.
@en
P2093
Derek V Chan
Ming-Hsien Chien
Rahul Sharma
Tsung-Ching Lai
Wei-Jiunn Lee
Wei-Min Chang
Yu-Chan Chang
Yuan-Feng Lin
P2860
P304
P356
10.1158/1535-7163.MCT-16-0314
P577
2017-03-14T00:00:00Z